Literature DB >> 21626556

Milestones in huntington disease.

Ira Shoulson1, Anne B Young.   

Abstract

There have been extraordinary advances in our knowledge of the underlying gene, the protein it encodes, various models of disease, and potential targets for effective therapies for Huntington disease. Huntington disease research has increased exponentially in the past 25 years, and we now understand many of the molecular mechanisms underlying the disease. Still, more work needs to be done before we have a full understanding of the pathophysiology of the disease. Clinical research on biomarkers and clinical trials on potential neuroprotective agents are underway. Here we review our progress in these areas over the last 25 years and speculate on what the next 25 years may hold.
Copyright © 2011 Movement Disorder Society.

Entities:  

Mesh:

Year:  2011        PMID: 21626556     DOI: 10.1002/mds.23685

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  22 in total

1.  Taking a break from huntingtin.

Authors:  Beverly L Davidson
Journal:  Mol Ther       Date:  2012-10       Impact factor: 11.454

Review 2.  MicroRNAs in glaucoma and neurodegenerative diseases.

Authors:  Milena Molasy; Anna Walczak; Jerzy Szaflik; Jacek P Szaflik; Ireneusz Majsterek
Journal:  J Hum Genet       Date:  2016-07-14       Impact factor: 3.172

Review 3.  Neurological Disorders Associated with Striatal Lesions: Classification and Diagnostic Approach.

Authors:  Davide Tonduti; Luisa Chiapparini; Isabella Moroni; Anna Ardissone; Giovanna Zorzi; Federica Zibordi; Sergio Raspante; Celeste Panteghini; Barbara Garavaglia; Nardo Nardocci
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081

4.  Factors related to genetic testing in adults at risk for Huntington disease: the prospective Huntington at-risk observational study (PHAROS).

Authors:  K A Quaid; S W Eberly; E Kayson-Rubin; D Oakes; I Shoulson
Journal:  Clin Genet       Date:  2016-11-24       Impact factor: 4.438

5.  Validation of a prognostic index for Huntington's disease.

Authors:  Jeffrey D Long; Douglas R Langbehn; Sarah J Tabrizi; Bernhard G Landwehrmeyer; Jane S Paulsen; John Warner; Cristina Sampaio
Journal:  Mov Disord       Date:  2016-11-28       Impact factor: 10.338

6.  The Changing Age of Individuals Seeking Presymptomatic Genetic Testing for Huntington Disease.

Authors:  Melissa A Holman; John Quillin; Timothy P York; Claudia M Testa; Ami R Rosen; Virginia W Norris
Journal:  J Genet Couns       Date:  2018-02-20       Impact factor: 2.537

7.  Abnormal nuclear envelopes in the striatum and motor deficits in DYT11 myoclonus-dystonia mouse models.

Authors:  Fumiaki Yokoi; Mai T Dang; Tong Zhou; Yuqing Li
Journal:  Hum Mol Genet       Date:  2011-11-11       Impact factor: 6.150

8.  Age-related length variability of polymorphic CAG repeats.

Authors:  Monica Sanchez-Contreras; Fernando Cardozo-Pelaez
Journal:  DNA Repair (Amst)       Date:  2016-10-15

9.  Huntington's disease (HD): degeneration of select nuclei, widespread occurrence of neuronal nuclear and axonal inclusions in the brainstem.

Authors:  Udo Rüb; Matthias Hentschel; Katharina Stratmann; Ewout Brunt; Helmut Heinsen; Kay Seidel; Mohamed Bouzrou; Georg Auburger; Henry Paulson; Jean-Paul Vonsattel; Herwig Lange; Horst-Werner Korf; Wilfred den Dunnen
Journal:  Brain Pathol       Date:  2014-03-03       Impact factor: 6.508

10.  A dynamic structural model of expanded RNA CAG repeats: a refined X-ray structure and computational investigations using molecular dynamics and umbrella sampling simulations.

Authors:  Ilyas Yildirim; HaJeung Park; Matthew D Disney; George C Schatz
Journal:  J Am Chem Soc       Date:  2013-02-26       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.